Immunologic Research, the follow-up journal of Paul Ehrlich’s Zeitschrift für Immunitätsforschung, represents a unique medium for the presentation, discussion and clarification of complex scientific data. The scope of the journal covers the entire spectrum of immunology from the molecular and cellular level to immunological diseases and clinical applications. By maintaining a balance between basic and clinical data Immunologic Research provides a platform for researchers, clinicians as well as experts from industry to bring laboratory findings into the clinics. Our journal also provides a platform to present historical reviews and landmark discoveries as well as to discuss novel measure to teach immunology during public events and in the class room. Editorials, guidelines and new techniques of innovative importance are also encouraged.
- Immunologic Research is a Transformative Journal (TJ). When a paper is accepted for publication, authors can choose to publish using either the traditional publishing route or immediate gold Open Access (Funding available! Please see: https://www.springer.com/journal/12026/open-access-publishing)
- Covers the entire spectrum of immunology from the molecular and cellular level to immunological diseases and clinical applications 93% of authors who answered a survey rated the overall publishing process as excellent or good for 2019
Journal information
- Editors-in-Chief
-
- Nicola Bizzaro,
- Hans-Martin Jäck
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 2.507 (2019)
- Impact factor
- 2.805 (2019)
- Five year impact factor
- 27 days
- Submission to first decision
- 118 days
- Submission to acceptance
- 188,882 (2020)
- Downloads
Latest issue
Latest articles
-
-
Association of interleukin-12B rs6887695 with susceptibility to allergic rhinitis
Authors (first, second and last of 7)
-
-
-
Potential role of viral infection and B cells as a linker between innate and adaptive immune response in systemic lupus erythematosus
Authors (first, second and last of 8)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
About this journal
- Electronic ISSN
- 1559-0755
- Print ISSN
- 0257-277X
- Abstracted and indexed in
-
- AGRICOLA
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Dimensions
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EMBASE
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Agricultural & Environmental Science Database
- ProQuest Algology, Mycology and Protozoology Abstracts (Microbiology C)
- ProQuest Bacteriology Abstracts (Microbiology B)
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Environmental Science
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Immunology Abstracts
- ProQuest Industrial and Applied Microbiology Abstracts (Microbiology A)
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Pharma Collection
- ProQuest Public Health Database
- ProQuest SciTech Premium Collection
- ProQuest Virology and AIDS Abstracts
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature